WallStreetZenWallStreetZen

NASDAQ: VALN
Valneva Se Stock Forecast, Predictions & Price Target

Analyst price target for VALN

Based on 1 analyst offering 12 month price targets for Valneva Se.
Min Forecast
$26.00+258.62%
Avg Forecast
$26.00+258.62%
Max Forecast
$26.00+258.62%

Should I buy or sell VALN stock?

Based on 1 analyst offering ratings for Valneva Se.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VALN stock forecasts and price targets.

VALN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-15

1 of 1

Forecast return on equity

Is VALN forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
24.42%

Forecast return on assets

Is VALN forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

VALN revenue forecast

What is VALN's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$295.3M+24.34%
Avg 2 year Forecast
$283.0M+19.2%
Avg 3 year Forecast
$418.2M+76.11%
VALN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VALN revenue growth forecast

How is VALN forecast to perform vs Biotechnology companies and vs the US market?
Company
20.76%
Industry
48.24%
Market
9.9%
VALN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VALN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VALN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VALN$7.25$26.00+258.62%Buy
TERN$8.08$10.83+34.07%Buy
NRIX$10.04$23.00+129.08%Strong Buy
LIAN$4.79$5.33+11.34%Hold
LBPH$20.42$36.50+78.75%Strong Buy

Valneva Se Stock Forecast FAQ

Is Valneva Se Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: VALN) stock is to Buy VALN stock.

Out of 1 analyst, 0 (0%) are recommending VALN as a Strong Buy, 1 (100%) are recommending VALN as a Buy, 0 (0%) are recommending VALN as a Hold, 0 (0%) are recommending VALN as a Sell, and 0 (0%) are recommending VALN as a Strong Sell.

If you're new to stock investing, here's how to buy Valneva Se stock.

What is VALN's revenue growth forecast for 2024-2026?

(NASDAQ: VALN) Valneva Se's forecast annual revenue growth rate of 20.76% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 48.24%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.9%.

Valneva Se's revenue in 2024 is $237,462,765.On average, 1 Wall Street analysts forecast VALN's revenue for 2024 to be $41,013,809,926, with the lowest VALN revenue forecast at $41,013,809,926, and the highest VALN revenue forecast at $41,013,809,926. On average, 2 Wall Street analysts forecast VALN's revenue for 2025 to be $39,318,387,232, with the lowest VALN revenue forecast at $36,793,659,052, and the highest VALN revenue forecast at $41,843,115,413.

In 2026, VALN is forecast to generate $58,091,668,663 in revenue, with the lowest revenue forecast at $56,931,752,277 and the highest revenue forecast at $59,251,585,049.

What is VALN's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: VALN) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is VALN's Price Target?

According to 1 Wall Street analyst that have issued a 1 year VALN price target, the average VALN price target is $26.00, with the highest VALN stock price forecast at $26.00 and the lowest VALN stock price forecast at $26.00.

The Wall Street analyst predicted that Valneva Se's share price could reach $26.00 by Feb 15, 2025. The average Valneva Se stock price prediction forecasts a potential upside of 258.62% from the current VALN share price of $7.25.

What is VALN's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: VALN) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.